| 2025 | 2024 | 2023 | 2022 | 2021 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 246,0 k € | +11.9% | 219,8 k € | -5.1% | 231,6 k € | +17.2% | 197,7 k € | -7.2% | 213,0 k € | +12.9% | 188,6 k € | +115.3% | 87,6 k € | -28.8% | 123,1 k € | +10.2% | 111,7 k € | -40.8% | 188,8 k € | +20.4% | 156,7 k € | -12.0% | 178,1 k € | -30.3% | 255,7 k € | +16.8% | 218,9 k € | +84.1% | 118,9 k € | +52.6% | 77,9 k € | -48.9% | 152,6 k € | |
| EBITDA | 241,1 k € | +10.3% | 218,6 k € | -5.3% | 230,7 k € | +17.3% | 196,7 k € | -7.0% | 211,6 k € | +13.3% | 186,7 k € | +116.3% | 86,3 k € | -28.6% | 121,0 k € | +9.9% | 110,1 k € | -41.3% | 187,6 k € | +20.6% | 155,5 k € | -11.9% | 176,6 k € | -29.9% | 252,0 k € | +15.6% | 218,1 k € | +84.7% | 118,1 k € | +53.4% | 77,0 k € | -49.4% | 152,2 k € | |
| Operating profit | 230,2 k € | +14.5% | 201,0 k € | -2.1% | 205,4 k € | +44.3% | 142,3 k € | -18.1% | 173,8 k € | +44.8% | 120,0 k € | +708.2% | 14,8 k € | -68.8% | 47,6 k € | +44.1% | 33,0 k € | -74.1% | 127,7 k € | +28.3% | 99,6 k € | -20.2% | 124,8 k € | -37.2% | 198,8 k € | +9.2% | 182,1 k € | +102.4% | 90,0 k € | +68.7% | 53,3 k € | -61.2% | 137,4 k € | |
| Profit/loss | 160,2 k € | +15.9% | 138,2 k € | -1.7% | 140,6 k € | +40.1% | 100,3 k € | -17.4% | 121,4 k € | +49.3% | 81,3 k € | +1087.5% | 6,9 k € | -74.2% | 26,6 k € | +90.8% | 13,9 k € | -82.7% | 80,3 k € | +19.5% | 67,2 k € | -20.0% | 84,1 k € | -35.1% | 129,5 k € | +7.4% | 120,5 k € | +92.2% | 62,7 k € | +71.0% | 36,7 k € | -59.7% | 91,0 k € | |
| Equity | 772,2 k € | +26.2% | 612,0 k € | -0.3% | 614,1 k € | +27.8% | 480,4 k € | +10.7% | 433,9 k € | +27.3% | 340,8 k € | -19.4% | 422,9 k € | +1.6% | 416,0 k € | +6.8% | 389,5 k € | +3.7% | 375,5 k € | +199.1% | 125,6 k € | -56.2% | 286,8 k € | +41.5% | 202,7 k € | +176.6% | 73,3 k € | -63.9% | 202,7 k € | +44.8% | 140,0 k € | +35.5% | 103,4 k € | |
| Total assets | 1,2 M € | +6.5% | 1,1 M € | +38.9% | 790,2 k € | +20.1% | 657,8 k € | +39.4% | 471,8 k € | -19.0% | 582,4 k € | +5.5% | 551,8 k € | +1.0% | 546,5 k € | -2.5% | 560,5 k € | +6.6% | 526,0 k € | +3.4% | 508,9 k € | +3.3% | 492,6 k € | -0.5% | 495,1 k € | +15.3% | 429,2 k € | +39.0% | 308,7 k € | +24.9% | 247,1 k € | +23.4% | 200,2 k € | |
| Cash | 429,0 k € | -28.9% | 603,3 k € | +187.0% | 210,3 k € | -23.4% | 274,6 k € | +26.8% | 216,5 k € | -8.0% | 235,3 k € | +78.0% | 132,1 k € | +14.7% | 115,2 k € | -4.5% | 120,7 k € | -2.5% | 123,9 k € | -16.2% | 147,9 k € | +182.8% | 52,3 k € | -46.8% | 98,2 k € | -17.5% | 119,0 k € | +2983.4% | 3,9 k € | -87.6% | 31,0 k € | -36.4% | 48,8 k € | |
| Debts | 397,1 k € | -18.2% | 485,7 k € | +175.9% | 176,0 k € | -0.6% | 177,2 k € | +367.1% | 37,9 k € | -84.3% | 241,6 k € | +87.4% | 129,0 k € | -1.2% | 130,5 k € | -23.7% | 171,1 k € | +13.7% | 150,5 k € | -60.7% | 383,4 k € | +86.3% | 205,8 k € | -29.6% | 292,3 k € | -17.9% | 356,0 k € | +247.9% | 102,3 k € | +54.1% | 66,4 k € | +5.9% | 62,7 k € | |
Private limited company · Lubbeek · incorporated on 01/03/2007
Private limited company profitable and well capitalised. Cash position declining (-28.9%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Dr. Van Nuffel Jan is a Private limited company incorporated in 2007. Its main activity is: Other human health activities. Its registered office is in Lubbeek.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette